Refine
Has Fulltext
- yes (11)
Is part of the Bibliography
- yes (11) (remove)
Document Type
- Journal article (10)
- Doctoral Thesis (1)
Keywords
- giant cell arteritis (2)
- magnetic resonance imaging (2)
- scleroderma (2)
- systemic sclerosis (2)
- Atherosclerosis, intracranial arteries (1)
- Autologous hematopoietic stem cell transplantation (1)
- B cell culture (1)
- B cells (1)
- CMV reactivation (1)
- ERBB receptors (1)
- GCA (1)
- GIRK (1)
- Heteromerisierung (1)
- Infectious complications (1)
- LRIG1 (1)
- PMR (1)
- S100A8/S100A9 (1)
- Serotonin (1)
- Serotonin-1A (1)
- Serotonin-7 (1)
- Systemic sclerosis (1)
- TASK-1 (1)
- [18F]FDG PET/CT (1)
- adverse events (1)
- aging (1)
- autologous hematopoietic stem cell transplantation (1)
- bone QCT (1)
- c-reactive protein (1)
- calprotectin (1)
- common variable immunodeficiency (CVID) (1)
- cytokines (1)
- exercise (1)
- genital warts (1)
- heteromerisation (1)
- human papillomavirus (1)
- immunophenotyping (1)
- immunosuppression (1)
- inborn errors of immunity (IEIs) (1)
- inflammation (1)
- inflammation marker (1)
- large artery vasculitis (1)
- melanoma (1)
- memory B cells (1)
- mouse model (1)
- mycophenolate (1)
- ophthalmic artery (1)
- optic nerve (1)
- orbit (1)
- osteoporosis (1)
- polymyalgia rheumatica (1)
- primary immunodeficiency (1)
- rheumatoid arthritis (1)
- rituximab (1)
- sarcopenia (1)
- serotonin (1)
- serotonin-1A (1)
- serotonin-7 (1)
- skin carcinogenesis (1)
- tocilizumab (1)
- vasa vasorum (1)
- vasculature (1)
- vasculitis (1)
- vertebral artery (1)
- γδ T cells (1)
Institute
- Medizinische Klinik und Poliklinik II (7)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Augenklinik und Poliklinik (1)
- Frauenklinik und Poliklinik (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Lehrstuhl für Orthopädie (1)
- Physikalisches Institut (1)
- Physiologisches Institut (1)
Background
Assessing serological inflammation is difficult in tocilizumab (TCZ)-treated rheumatoid arthritis (RA) patients, as standard inflammation parameters, like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are influenced by interleukin-6-receptor inhibition. Calprotectin in the serum, also named S100A8/S100A9, might be a more useful inflammation parameter in TCZ-treated patients.
Methods
Sixty-nine RA patients taking TCZ were included. Serum-calprotectin levels were assessed, as well as ESR, CRP, need for a change in disease-modifying anti-rheumatic drugs due to RA activity (= active RA), and the RA clinical disease activity score (CDAI). Forty-five RA patients taking tumor-necrosis factor-inhibitors (TNFi) were investigated for the same parameters.
Results
TCZ-treated patients with active RA had higher calprotectin values than not active RA patients (4155.5 [inter quartile range 1865.3–6068.3] vs 1040.0 [676.0–1638.0] ng/ml, P < 0.001). A calprotectin cut-off value of 1916.5 ng/ml resulted in a sensitivity and specificity of 80.0 %, respectively, for the detection of RA disease activity. Calprotectin values correlated with CDAI-scores (r = 0.228; P = 0.011). ESR and CRP were less suitable to detect RA activity in TCZ-treated patients. Also TNFi-treated patients with active RA had higher calprotectin values compared to not active RA (5422.0 [3749.0–8150.8] vs 1845.0 [832.0–2569.0] ng/ml, P < 0.001). The calprotectin value with the best sensitivity and specificity for detecting RA activity was 3690.5 ng/ml among TNFi-treated patients.
Conclusion
Calprotectin in the serum can be a useful inflammation parameter despite TCZ-treatment.